132 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
Page next »
CACNA1A Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit Disease related genes Nucleoplasm Tissue enhanced
CACNA1B Calcium channel, voltage-dependent, N type, alpha 1B subunit Disease related genes Group enriched
CACNA1C Calcium channel, voltage-dependent, L type, alpha 1C subunit Disease related genes Tissue enhanced
CACNA1D Calcium channel, voltage-dependent, L type, alpha 1D subunit Cancer-related genes Nuclear membrane Mixed
CACNA1E Calcium channel, voltage-dependent, R type, alpha 1E subunit Predicted membrane proteins Plasma membrane Tissue enriched
CACNA1F Calcium channel, voltage-dependent, L type, alpha 1F subunit Disease related genes Mixed
CACNA1G Calcium channel, voltage-dependent, T type, alpha 1G subunit FDA approved drug targets Tissue enhanced
CACNA1H Calcium channel, voltage-dependent, T type, alpha 1H subunit Disease related genes Nucleoplasm Tissue enhanced
CACNA1I Calcium channel, voltage-dependent, T type, alpha 1I subunit FDA approved drug targets Tissue enhanced
CACNA1S Calcium channel, voltage-dependent, L type, alpha 1S subunit Disease related genes Tissue enriched
CATSPER2 Cation channel, sperm associated 2 Disease related genes Tissue enhanced
CATSPER4 Cation channel, sperm associated 4 Predicted membrane proteins Tissue enriched
CNGA1 Cyclic nucleotide gated channel alpha 1 Disease related genes Vesicles Mixed
CNGA2 Cyclic nucleotide gated channel alpha 2 Predicted membrane proteins Not detected
CNGA3 Cyclic nucleotide gated channel alpha 3 Disease related genes Mixed
CNGA4 Cyclic nucleotide gated channel alpha 4 Predicted intracellular proteins Group enriched
CNGB3 Cyclic nucleotide gated channel beta 3 Disease related genes Tissue enhanced
HCN1 Hyperpolarization activated cyclic nucleotide gated potassium channel 1 Disease related genes Tissue enriched
HCN2 Hyperpolarization activated cyclic nucleotide gated potassium channel 2 Predicted membrane proteins Group enriched
HCN3 Hyperpolarization activated cyclic nucleotide gated potassium channel 3 Plasma proteins Mixed
HCN4 Hyperpolarization activated cyclic nucleotide gated potassium channel 4 Disease related genes Group enriched
KCNA1 Potassium channel, voltage gated shaker related subfamily A, member 1 Disease related genes Tissue enriched
KCNA10 Potassium channel, voltage gated shaker related subfamily A, member 10 FDA approved drug targets Nucleoplasm Tissue enhanced
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Mixed
KCNA4 Potassium channel, voltage gated shaker related subfamily A, member 4 FDA approved drug targets Tissue enhanced
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes Tissue enhanced
KCNA6 Potassium voltage-gated channel subfamily A member 6 FDA approved drug targets Not detected
KCNA7 Potassium channel, voltage gated shaker related subfamily A, member 7 FDA approved drug targets Tissue enriched
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes Tissue enhanced
KCNB2 Potassium channel, voltage gated Shab related subfamily B, member 2 FDA approved drug targets Nucleoli Tissue enhanced
KCNC1 Potassium channel, voltage gated Shaw related subfamily C, member 1 Disease related genes Nucleus Tissue enriched
KCNC2 Potassium channel, voltage gated Shaw related subfamily C, member 2 FDA approved drug targets Plasma membrane Tissue enriched
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes Tissue enhanced
KCNC4 Potassium channel, voltage gated Shaw related subfamily C, member 4 Predicted membrane proteins Nucleoli Mixed
KCND1 Potassium channel, voltage gated Shal related subfamily D, member 1 FDA approved drug targets Nucleus Mixed
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes Mixed
KCNF1 Potassium channel, voltage gated modifier subfamily F, member 1 Plasma proteins Golgi apparatus Tissue enriched
KCNG1 Potassium channel, voltage gated modifier subfamily G, member 1 Predicted intracellular proteins Vesicles Tissue enhanced
KCNG2 Potassium channel, voltage gated modifier subfamily G, member 2 Predicted membrane proteins Not detected
KCNG3 Potassium channel, voltage gated modifier subfamily G, member 3 Predicted membrane proteins Cytoplasmic bodies Tissue enhanced
KCNG4 Potassium channel, voltage gated modifier subfamily G, member 4 Predicted membrane proteins Not detected
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Vesicles Tissue enriched
KCNH2 Potassium channel, voltage gated eag related subfamily H, member 2 Disease related genes Tissue enhanced
KCNH3 Potassium channel, voltage gated eag related subfamily H, member 3 Predicted membrane proteins Nucleus Group enriched
KCNH4 Potassium channel, voltage gated eag related subfamily H, member 4 Predicted membrane proteins Tissue enhanced
KCNH5 Potassium channel, voltage gated eag related subfamily H, member 5 Predicted membrane proteins Microtubules Tissue enhanced
KCNH6 Potassium channel, voltage gated eag related subfamily H, member 6 Predicted membrane proteins Tissue enhanced
KCNH7 Potassium channel, voltage gated eag related subfamily H, member 7 Predicted membrane proteins Tissue enriched
Page next »
